GSK (GSK) plc announces the commencement of its share buyback program, as announced in its 2024 full year results announcement published on 5 ...

GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the ...

Ben Hargreaves examines the reasons supplied by the survey and why GSK is invested in the answers. The emergence of COVID-19 meant that public awareness around vaccination and its importance in ...

GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.

On Feb. 26th, students and school staff across Saskatchewan dressed in pink shirts to advocate for a world without bullying.

Teva Pharmaceutical Industries Ltd. ADR-2.74% $19.5B ...

After hours: 7:50:35 pm GMT-5 ...

Vaccine makers face a demand cliff as coronavirus vaccines wane, but these stocks are more than meets the eye.

While the UN Global Compact logo is for use by our initiative only, we encourage participants in good standing to use the Endorser "We Support" logo. It can be used, for example, on websites and ...

After hours: 7:55:57 p.m. EST ...